Search Results - "Rongen, G.A."

Vascular Consequences Of Interruption Of Tnf-Inhibitor Therapy In Patients With Rheumatoid Arthritis by Rongen, G.A, Van Ingen, I, Jansen, T.L

“…Forearm vasodilation to acetylcholine (ACh, endothelium-dependent vasodilator) and sodium nitroprusside (SNP; nitric oxide-donor) were assessed before…”
Get full text

Eplerenone does not limit ischemia–reperfusion injury in human myocardial tissue by van den Berg, T.N.A. (Daniëlle), van Swieten, H.A, Vos, J.C, Verweij, V, Wouterse, A.C, Deinum, J, Morshuis, W.J, Rongen, G.A, Riksen, N.P

“…Abstract Background Despite rapid reperfusion, mortality and morbidity in patients with an acute myocardial infarction remain significant. Therefore, novel…”
Get full text

The Effect Of Eplerenone On Adenosine Formation In Humans In Vivo: A Double-Blinded Randomized Controlled Study by van den Berg, T.N.A, Deinum, J, Bilos, A, Rongen, G.A, Riksen, N.P

“…Conclusion At a dosage of 50 mg BID, eplerenone did not augment extracellular adenosine formation in healthy human subjects. [...]it is unlikely that an…”
Get full text

Early Rise in Aldosteron is Correlated with Increase in Blood Pressure in Sunitinib Treated Patients with Metastatic Renal Cell Carcinoma by Thijs, A, van Herpen, C, van der Graaf, W.T.A, Rongen, G.A

“…[...]it is not clear whether these changes are a result or cause of the rise in blood pressure. [...]we studied the early effects of sunitinib on renin and…”
Get full text

PP114—Sunitinib does not reduce endothelium-dependent vasodilation in humans by Thijs, A, van der Graaf, W.T, van Herpen, C.M, Rongen, G.A

Get full text

Sunitinib Does not Attenuate Contractile Force at Therapeutic Concentrations Following a Period of Ischemia in Isolated Human Cardiac Muscle by Thijs, A.M, Vos, A, Wouterse, A, El Messaoudi, S, van Swieten, H, Verweij, V, Herpen, C.M, van der Graaf, W.T.A, Noyez, L, Rongen, G.A

“…Introduction Patients treated for cancer with the tyrosine kinase inhibitor sunitinib are at increased risk for development of heart failure, particularly…”
Get full text

Dipyridamole Does not Limit Myocardial Ischemia-Reperfusion Injury. A Double-Blind Randomized Placebo-Controlled Trial in Patients Undergoing Elective Coronary Artery Bypass Surgery by El Messaoudi, S, Wouters, C.W, van Swieten, H.A, Pickkers, P, Noyez, L, Kievit, P.C, Abbink-Zandbergen, E.J, Rasing-Hoogveld, A, Bouw, M.P, Peters, J.G.P, Coenen, M.J.H, Donders, A.R.T, Riksen, N.P, Rongen, G.A

“…Conclusion Dipyridamole before CABG did not significantly reduce postoperative troponin release. [...]oral dipyridamole does not prevent ischemia-reperfusion…”
Get full text

P1.33 Angiotensin-II contributes to the increased leg vascular resistance in spinal cord-injured individuals by Groothuis, J.T, Thijssen, D.H.J, Deinum, J, Rongen, G.A, Smits, P, Hopman, M.T.E

Get full text

2.6 - Vascular Consequences Of Interruption Of Tnf-Inhibitor Therapy In Patients With Rheumatoid Arthritis by Rongen, G.A., Van Ingen, I., Jansen, T.L.

Get full text

Rosuvastatin increases extracellular adenosine in humans in vivo: A New perspective on cardiovascular protection by Meijer, P, Oyen, W.J.G, Dekker, D, van den Broek, P.H.H, Wouters, C.W, Boerman, O.C, Scheffer, G.J, Smits, P, Rongen, G.A

Get full text

PP.16.18: EFFECT OF SODIUM CHLORIDE INTAKE ON BLOOD PRESSURE RESPONSE TO CAFFEINE CONTAINING COFFEE IN HUMANS by Esselink, A., Bril, L.M., Langenhuijsen, R., Bilos, A., Rongen, G.A.

Get full text

P1.07 Rosuvastatin Increases Extracellular Adenosine in Humans in Vivo: A New Perspective on Cardiovascular Protection by Meijer, P., Oyen, W. J. G., Dekker, D., van den Broek, P. H. H., Wouters, C. W., Boerman, O. C., Scheffer, G. J., Smits, P., Rongen, G. A.

“…Background Increased extracellular adenosine formation provides a cholesterol-independent explanation for the therapeutic benefit of statins. This theory was…”
Get full text

Patients with primary aldosteronism have lower circulating adenosine levels but similar susceptibility to ischemia-reperfusion compared to patients with essential hypertension by Van Den Berg, D., van Mil, A.C., Deinum, J., van den Broek, P.H., Rongen, G.A., Monajemi, H., Thijssen, D.H., Riksen, N.P.

Get full text

Changes in Insulin Clearance During Sunitinib Treatment by Thijs, A.M., Tack, C.J., van der Graaf, W.T.A., Rongen, G.A., van Herpen, C.

Get full text

1515PCHANGES IN INSULIN CLEARANCE DURING SUNITINIB TREATMENT by Thijs, A.M., Tack, C.J., van der Graaf, W.T.A., Rongen, G.A., van Herpen, C.

“…Abstract Aim: Sunitinib, a VEGFR tyrosine kinase inhibitor (TKI) is registered in metastatic renal cell carcinoma (mRCC), gastrointestinal stromal tumor (GIST)…”
Get full text

EACPT-0028 - Early Rise in Aldosteron is Correlated with Increase in Blood Pressure in Sunitinib Treated Patients with Metastatic Renal Cell Carcinoma by Thijs, A., van Herpen, C., van der Graaf, W.T.A., Rongen, G.A.

Get full text

EACPT-0020 - The Effect Of Eplerenone On Adenosine Formation In Humans In Vivo: A Double-Blinded Randomized Controlled Study by van den Berg, T.N.A., Deinum, J., Bilos, A., Rongen, G.A., Riksen, N.P.

Get full text

EACPT-0034 - Salvia Miltiorrhiza Water-Extract (Danshen) has No Beneficial Effect on Cardiovascular Risk Factors by van Poppel, P.C.M., Breedveld, P., Abbink, E., Schaap-Roelofs, H., van Heerde, W., Smits, P., Lin, W., Tan, H.H., Russel, F.G., Donders, R., Tack, C.J., Rongen, G.A.

Get full text

Eacpt-0029 - Sunitinib Does not Attenuate Contractile Force at Therapeutic Concentrations Following a Period of Ischemia in Isolated Human Cardiac Muscle by Thijs, A.M., Vos, A., Wouterse, A., El Messaoudi, S., van Swieten, H., Verweij, V., Herpen, C.M., van der Graaf, W.T.A., Noyez, L., Rongen, G.A.

Get full text

Salvia Miltiorrhiza Water-Extract (Danshen) has No Beneficial Effect on Cardiovascular Risk Factors by van Poppel, P.C.M., Breedveld, P., Abbink, E., Schaap-Roelofs, H., van Heerde, W., Smits, P., Lin, W., Tan, H.H., Russel, F.G., Donders, R., Tack, C.J., Rongen, G.A.

Get full text